Priapism: Difference between revisions
(minor change) |
|||
| Line 34: | Line 34: | ||
== Treatment == | == Treatment == | ||
#Regardless of treatment there is a high risk of impotence | #Written consent prior to invasive procedure | ||
# | ##Regardless of treatment there is a high risk of impotence | ||
# | #Pain control | ||
#IV hydration | ##Morphine and/or penile block | ||
#O2 | #If sickle cell: | ||
#Transfusion | ##IV hydration | ||
##O2 | |||
##Transfusion for goal HCT>30% with possible exchange transfusion (HGB-S<30%) | |||
#Urology consult (especially important with traumatic priapism) | #Urology consult (especially important with traumatic priapism) | ||
#α/β-2 Agonists | #α/β-2 Agonists | ||
Revision as of 05:37, 5 January 2014
Background
- Prolonged, unwanted erection not a/w sexual stimulation > 4h
- May lead to erectile dysfunction and penile necrosis if untreated
- 2 types:
- 1. High-flow (nonischemic)
- AV fistula from trauma (lacerated cavernous artery shunts blood into cavernous bodies)
- Usually not painful
- Ischemia/impotence does not occur
- 2. Low-flow (ischemic) - more common
- Veno-occlusion causing pooling of deoxygenated blood in cavernous tissue
- Assoc w/ sickle cell, meds, trauma, leukemia, infection, spinal cord injury/cauda equina, hypercoag
- Painful
- Fibrotic change leads to impotence
- Veno-occlusion causing pooling of deoxygenated blood in cavernous tissue
- 1. High-flow (nonischemic)
Clinical Features
- Erect corpus cavernosum
- Flacid glans and spongiosum
Work-Up
- CBC (eval leukemia, sickle cell)
- Type and screen (may need to exchange transfusion)
- Coags
- Urinalysis/tox (etoh, marijuana, cocaine can cause priapism)
- ABG from cavernosa (if hx unclear): Hypoxic, hypercapneic, acidotic → low flow
- Ultrasound
- Can distinguish between high-flow and low-flow
DDx
- Peyronie's Disease
- Urethral foreign body
- Penile surgical implant
- Erection from sexual arousal
Treatment
- Written consent prior to invasive procedure
- Regardless of treatment there is a high risk of impotence
- Pain control
- Morphine and/or penile block
- If sickle cell:
- IV hydration
- O2
- Transfusion for goal HCT>30% with possible exchange transfusion (HGB-S<30%)
- Urology consult (especially important with traumatic priapism)
- α/β-2 Agonists
- Terbutaline 0.25-0.5mg SQ in deltoids OR 5-10mg PO, may repeat in q20min
- Oral pseudoephedrine 60-120mg PO
- Injection of phenylephrine
- Dilute phenylephrine in normal saline to provide final concentration of 100-500mcg/mL (1amp phenylephrine (1mL:1000mcg) with 9mL NS)
- Inject base of penis with 29-Ga needle (after blood aspiration to confirm position) 0.5-1mL q3-5min until resolution or one hour (max 1500mcg)
- Only one side needs to be injected (vascular channel b/w 2 corpora cavernosa)
- Compress injection area to prevent hematoma formation
- Use with caution in cardiovasc disease
- Aspiration of corpus cavernosum
- Rarely beneficial after 48hr
- Local anesthesia at puncture
- Occasionally a penile block may be needed
- Use 27G needle for penile nerve block at 2 and 10 o'clock position at base of penis (or penile ring block)
- Aspirate blood from corpus cavernosum (3 or 9 o'clock position of shaft) w/ 16-19ga needle
- Blood sludging makes aspiration difficult, so to improve flow dynamics use saline irrigation and repeated aspirations
- After removal of 20-30cc of blood, you may inject and aspirate 10-20cc aliquots (200-500mcg) of a phenylephrine (10mg/500ml NS) or norepi (1mg/500cc NS) containing solution. If neither is available, epi can be used, but use caution due to adverse effects
- Wrap penis in elastic bandage after detumescence is achieved
Disposition
- Admit if refractory to treatment
- May dispo home if treatment is successful with close follow-up by urology
Source
- Tintinalli
- UpToDate
- emedicine
- Roberts
